학술논문

Development and validation of a virtual reality transrectal ultrasound guided prostatic biopsy simulator
Document Type
Report
Source
Canadian Urological Association Journal (CUAJ). February 1, 2011, Vol. 5 Issue 1, p19, 8 p.
Subject
Canada
Language
English
ISSN
1911-6470
Abstract
Objective We present the design, reliability, face, content and construct validity testing of a virtual reality simulator for transrectal ultrasound (TRUS), which allows doctors-in-training to perform multiple different biopsy schemes. Methods This biopsy system design uses a regular [quote]end-firing[quote] TRUS probe. Movements of the probe are tracked with a micro-magnetic sensor to dynamically slice through a phantom patient s 3D prostate volume to provide real-time continuous TRUS views. 3D TRUS scans during prostate biopsy clinics were recorded. Intrinsic reliability was assessed by comparing the left side of the prostate to the right side of the prostate for each biopsy. A content and face validity questionnaire was administered to 26 doctors to assess the simulator. Construct validity was assessed by comparing notes from experts and novices with regards to the time taken and the accuracy of each biopsy. Results Imaging data from 50 patients were integrated into the simulator. The completed VR TRUS simulator uses real patient images, and is able to provide simulation for 50 cases, with a haptic interface that uses a standard TRUS probe and biopsy needle. Intrinsic reliability was successfully demonstrated by comparing results from the left and right sides of the prostate. Face and content validity respondents noted the realism of the simulator, and its appropriateness as a teaching model. The simulator was able to distinguish between experts and novices during construct validity testing. Conclusions A virtual reality TRUS simulator has successfully been created. It has promising face, content and construct validity results. Objectif Nous presentons le plan, la fiabilite, la validite apparente, de contenu et conceptuelle d un simulateur virtuel d echographie transrectale permettant aux medecins en cours de formation d executer de nombreux schemas differents de biopsie. Methodologie Ce systeme de biopsie est muni d une sonde a echographie transrectale habituelle a [less than][less than] emission verticale [greater than][greater than]. Les mouvements de la sonde sont suivis grace a un capteur micromag-netique permettant pratiquer des incisions de facon dynamique dans un volume prostatique virtuel en 3 dimensions et de produire des images continues en temps reel. Les images en 3 dimensions obtenues pendant des stages de biopsie prostatique ont ete enreg-istrees. La fiabilite intrinseque a ete evaluee en comparant le cote gauche et le cote droit de la prostate pour chaque biopsie. On a evalue le simulateur grace a un questionnaire portant sur le contenu et la validite apparente rempli par 26 medecins. La valid-ite conceptuelle a ete evaluee en comparant les notes provenant d experts et de debutants quant au temps requis pour effectuer les biopsies et a la precision de chaque biopsie. Resultats Les images provenant de 50 patients ont ete integrees au simulateur. Le simulateur d echographie transrectale virtuelle utilise de vraies images de patients et peut fournir une simulation pour 50 cas, avec une interface haptique fondee sur une sonde d echographie transrectale et une aiguille de biopsie standard. La fiabilite intrinseque a ete demontree avec succes en comparant les resultats des cotes gauche et droit de la prostate. Les repondants des questionnaires de validite apparente et de contenu ont note le realisme du simulateur, et son adequation en tant que modele d apprentissage. Le simulateur a ete en mesure de faire la distinction entre les experts et les debutants pendant l analyse de la validite conceptuelle. Conclusions Un simulateur virtuel d echographie transrectale effi-cace a ete cree. Il a genere des resultats prometteurs lors de tests de la validite apparente, de contenu et conceptuelle.
Author(s): Venu Chalasani, MD [1], Derek W. Cool, MD [2], Shi Sherebrin, MD [2], Aaron Fenster, MD [2], Joseph Chin, MD, FRCSC [1], Jonathan I Izawa, MD, FRCSC [1] Introduction [...]